摘要
CMR ameliorates lung histopathological injury, oxidative stress, and inflammatory response in COPD rats. • CMR suppresses EMT and ERS in a rat model of COPD. • CMR suppresses TGF-β1-induced fibroblast migration and invasion through the inhibition of ERS. • CMR alleviates TGF-β1-induced oxidative stress, inflammation, and fibrosis in fibroblasts via ERS inhibition. • CMR inhibits TGF-β1-induced fibroblast activation by suppressing the ERS pathway. Background Chronic obstructive pulmonary disease (COPD) is a heterogeneous condition defined by persistent airway inflammation. While traditional Chinese medicine offers distinct advantages in its management, the pharmacological effects and mechanisms of cortex mori radices (CMR) in COPD remain largely unexplored. Methods A cigarette smoke-induced COPD rat model and a transforming growth factor‑β1 (TGF‑β1)‑stimulated MRC‑5 fibroblast model were established. To evaluate the therapeutic effects, multiple endpoint indicators were assessed, including histopathology by hematoxylin‑eosin (HE) staining; oxidative stress markers including malondialdehyde (MDA), glutathione peroxidase (GSH‑Px), and superoxide dismutase (SOD); inflammatory cytokines including tumor necrosis factor‑α (TNF‑α), interleukin‑6 (IL‑6), interleukin‑1β (IL‑1β), and monocyte chemoattractant protein‑1 (MCP‑1); and fibrosis and fibroblast activation by Transwell assay, wound healing assay, quantitative real‑time PCR (qRT‑PCR), and Western blot. Results Animal experiments confirmed that CMR alleviated lung injury in COPD rats, inhibited oxidative stress (reduced MDA levels and increased GSH-Px and SOD activities) and inflammatory factor levels (TNF-α, IL-6, IL-1β, MCP-1) ( P < 0.001), upregulated E-cadherin expression, and downregulated N-cadherin, COL-1, ATF6, GRP78, and XBP1 ( P < 0.05, P < 0.01, P < 0.001). Furthermore, in vitro rescue experiments using tunicamycin (TM) confirmed that endoplasmic reticulum stress (ERS) was successfully reactivated. Upon ERS activation, the CMR‑mediated inhibitory effects on TGF‑β1‑induced fibroblast activation, migration, invasion, oxidative stress, and inflammation were significantly reversed ( P < 0.05, P < 0.01, P < 0.001). Conclusion This study elucidates the mechanism by which CMR inhibits fibroblast inflammation and enhances lung function in COPD, highlighting its clinical potential as a promising candidate drug for combating COPD. Download: Download high-res image (205KB) Download: Download full-size image
危险品化学品经营许可证(带存储)